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Abstract
Recent advances in next-generation sequencing technologies have made it possible to generate large amounts of
sequence data with rare variants in a cost-effective way. Statistical methods that test variants individually are
underpowered to detect rare variants, so it is desirable to perform association analysis of rare variants by
combining the information from all variants. In this study, we use a Bayesian regression method to model all
variants simultaneously to identify rare variants in a data set from Genetic Analysis Workshop 17. We studied the
association between the quantitative risk traits Q1, Q2, and Q4 and the single-nucleotide polymorphisms and
identified several positive single-nucleotide polymorphisms for traits Q1 and Q2. However, the model also
generated several apparent false positives and missed many true positives, suggesting that there is room for
improvement in this model.
Background
Rare variants are genetic variants that have a minor
allele frequency (MAF) less than 1%. Many previous stu-
dies have suggested that rare variants generally have lar-
ger effects on a trait than common variants. Therefore
identification of rare variants has become an important
research topic in recent genome-wide association stu-
dies. Several statistical approaches have been developed
to tackle this problem. These methods include the
weighted sum statistic [1], combined multivariate and
collapsing [2], the comparison of rare variants found
exclusively in case subjects to those found only in con-
trol subjects [3,4], and the kernel-based adaptive cluster
[5]. Overall, the results observed from these studies indi-
cate that multiple rare variants collectively contribute to
the variations of the trait, suggesting that it is desirable
to use all variants together to identify the associated
genetic variants with a given phenotype.
Bayesian regression models have been used in animal
breeding to predict breeding values based on all avail-
able single-nucleotide polymorphisms (SNPs) [6]. Many
extensions of Bayesian regression models in this field
have been discussed by Gianola et al. [7]. Bayesian sto-
chastic variable selection methods have also provided an
alternative approach to genome-wide association studies
[8,9]. Srivastava and Chen [10] compared the perfor-
mance of a Bayesian stochastic variable selection
method with that of a penalized sparse regression
method and demonstrated that the Bayesian stochastic
variable selection outperformed the sparse regression
and also the single-SNP-based method. Yi and Zhi [11],
in a recent study, used Bayesian stochastic variable
selection for the identification of rare variants. However,
the studies by Srivastava and Chen [10] and Yi and Zhi
[11] did not estimate the probability that the SNP will
be associated with the phenotype given the data.
In the current study, we model common variants and
rare variants simultaneously using a Bayesian stochastic
variable selection method. We calculate the regression
coefficient and posterior probability of association of
each SNP and use them to measure the association
between each SNP and the given trait. The difference
between our method and those of Srivastava and Chen
[10] and Yi and Zhi [11] is that we estimate the poster-
ior probability that the SNP will be associated with the
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ber of SNPs associated with the given trait. We apply
this method to study the association for the quantitative
risk factors Q1, Q2, and Q4 in the Genetic Analysis
Workshop 17 (GAW17) data and successfully identify
several SNPs associated with the Q1 and Q2 traits.
Methods
Overall model
First, let us introduce the model and some notation. The
model is:
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2 , n is the number of individuals,
p is the number of SNPs, y is an n × 1 phenotype vec-
tor, X is an n × p matrix with entries being 0, 1, and 2
encoded for the genotypes AA, AB, and BB, respectively,
θ is a p × 1 latent variable vector with entries being 0
and 1 to perform variable selection, and a is a p ×1
regression coefficient vector. θ ∘ a indicates the ele-
ment-wise product between θ and a.I fθj =1 ,t h e naj
(SNP j) is included in the model; if θj =0 ,t h e naj is
excluded from the model. P(θj =1 )=π is the prior
probability that the SNP will be associated with the phe-
notype in question, where π is the same for all SNPs.
We assume that the prior probability for k is Binomial
(B(p, π)), where k is the number of SNPs that are asso-
ciated with a phenotype. aj is normally distributed with
mean 0 and variance sa
2 ,a n dsa
2 is the scaled inverse
chi-square distribution with scale parameter Sa and
degrees of freedom va. s e
2 follows the scaled inverse
chi-square distribution with scale parameter Sε and
degrees of freedom vε.
Posterior estimations
Based on Eq. (1), one can obtain the full conditional
probability functions (FCPFs) for the parameters (deriva-
tions not shown). The FCPF for s e
2 is the scaled
inverse chi-square distribution with scale parameter:
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In expression (2), xj is an n × 1 vector that corre-
sponds to the SNP j.
The FCPF for μ is the normal distribution with mean:
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The FCPF for aj is the normal distribution with mean
a  j and variance s e  2
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It is clear that the a  j is conditional on all other a  ′ j .
The FCPF for sa
2 of each locus is the scale inverse
chi-square distribution with scale parameter:
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and degrees of freedom kv  + a ,w h e r ea  is a vector in
which the a  j is not 0. To obtain k  ,w en e e dt od e c i d e
whether each SNP should be included in the model or
not. To make this decision, we need to calculate:
ff
ff
j
s
j
s
j
s
j
s
j
s
j
s
aq q
aq q
_ = ( ) = ()
= ( ) = ()
00
11
. (8)
In expression (8), a j
s
_ indicates that the aj are not in
the model in the sth Markov chain Monte Carlo
(MCMC) iteration; and f j
s
j
s aq _ = ( ) 0 is the likeli-
hood that the aj are not in the model in the sth MCMC
iteration and is given by:
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In addition, a j
s indicates that the aj are in the model
in the sth MCMC iteration; and f j
s
j
s aq= ( ) 1 is the
likelihood that the aj a r ei nt h em o d e li nt h esth
MCMC iteration and is given by:
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s () qp == 1 , and the posterior
distribution for π is the Beta distribution
(Beta(, ) 11 ++ − kp k  ). From these likelihoods and the
sampled π, we compute the value of expression (8), and
use this value to determine whether q j
s is 1 or 0. Pos-
terior estimations are based on the samples from the
given FCPFs using MCMC sampling.
MCMC sampling
MCMC sampling works as follows. For each MCMC
iteration, we first sample s e
2 from its FCPF and μ from
its FCPF. Next, for a1, a2, a3, …, aj, …, ap, we sample
from the FCPF for aj.W h e t h e raj is included in the
model or not is determined, and s j
2 is updated by s a  2 .
k  is estimated. Next we sample from the FCPF for sa
2 .
Finally, we sample π from Beta(, ) 11 ++ − kp k  .
We performed 15,000 MCMC iterations and used the
first 1,000 iterations as the burn-in period. The inclu-
sion probability for aj is based on the proportion of θj =
1 in all the MCMC samples after the burn-in period.
This probability is used as the posterior probability of
association (PPA) for each SNP.
Data set
The GAW17 data set includes 697 unrelated individuals;
each individual has 24,487 SNPs. The MAFs of the
SNPs range from 0.0717% to 49.9283% [12]. Our analy-
sis is based on quantitative traits Q1, Q2, and Q4. The
GAW17 answers show that Q1 is associated with 39
SNPs in 9 genes from the vascular endothelial growth
factor (VEGF) pathway, that Q2 is influenced by 72
SNPs in 13 genes related to cardiovascular risk and
inflammation, and that Q4 is not affected by any of the
available SNPs. There are 200 data replications for each
trait. We perform an analysis for each replication and
obtain the average regression coefficients and PPAs for
each SNP from the 200 data replications. We then use
the different cutoffs of the regression coefficients and
PPAs to compute a series of true-positive rates (TPRs)
and false-positive rates (FPRs). We use the receiver
operating characteristic (ROC) to compare the TPR and
the FPR as the cutoffs change and the area under the
curve (AUC) to measure the performance of the model.
Results and discussion
We analyzed the association between quantitative traits
Q1, Q2, and Q4 and the SNPs in the GAW17 data. For
each trait, we assigned a relative rank for each SNP on
the basis of the sorting of the absolute values of the
average regression coefficients and PPAs of all SNPs in
decreasing order. In our model, we estimated the num-
ber of SNPs associated with a trait. Using this number
( k  ), we identified the SNPs whose ranks are within the
range of this number.
For the Q1 trait, the range of the estimated number of
SNPs associated with Q1 is 3 to 8. Based on this range,
the SNPs whose average regression coefficients and
PPAs are within the top eight rankings are considered
associated with Q1 (Table 1). The ranks of C13S431,
C13S522, C13S523, C1S6533, and C4S1884 are within
the top eight. The GAW17 answers confirmed that all
five SNPs are truly associated with Q1. C13S431,
C13S522, and C13S523 are located in gene FLT1,
C1S6533 is located in gene ARNT, and C4S1884 is
located in gene KDR.
For the Q2 trait, the range of the estimated number of
SNPs associated with the Q2 is 2 to 6. Based on this
range, the SNPs whose average regression coefficients
and PPAs are within the top six rankings are considered
associated with Q2 (Table 2). We found that the ranks
of C6S5380, C6S5449, C6S5441, C8S442, and C10S3050
are within the top six. C6S5380 is located in gene
VNN1, C6S5449 and C6S5441 are in gene VNN3,
C8S442 is in gene LPL, and C10S3050 is a rare variant
in gene SIRT1 with a MAF = 0.002152. The GAW17
answers confirmed that all five SNPs are truly associated
with Q2. In our analysis, C10S3051 is also identified as
being associated with Q2. Compared with the GAW17
answers, this finding is a false-positive association. How-
ever, we found that C10S3051 is a synonymous muta-
tion and is identical to C10S3050. The positions of the
two SNPs are close together, suggesting that the two
SNPs may be in high linkage disequilibrium.
Table 1 Association analysis for trait Q1
Gene SNP Regression coefficient PPA MAF
FLT1 C13S431 2.501 (2) 0.243 (3) 0.017217
C13S522 2.188 (3) 0.264 (2) 0.027977
C13S523 9.027 (1) 0.998 (1) 0.066714
ARNT C1S6533 0.478 (6) 0.043 (4) 0.011478
KDR C4S1884 0.126 (42) 0.016 (8) 0.020803
The third and fourth columns are the average regression coefficients and
posterior probabilities of association (PPAs) out of 200 replications,
respectively. The numbers in parentheses for the regression coefficients
indicate the rank of the SNP based on sorting the absolute values of average
regression coefficients in decreasing order. The numbers in parentheses for
the PPAs indicate the rank of the SNP based on sorting the PPAs in
decreasing order. We use the same notation in Table 2.
Table 2 Association analysis for trait Q2
Gene SNP Regression coefficient PPA MAF
VNN1 C6S5380 0.251 (1) 0.077 (1) 0.170732
VNN3 C6S5449 0.194 (2) 0.015 (3) 0.010043
C6S5441 0.038 (25) 0.010 (4) 0.098278
LPL C8S442 0.152 (5) 0.016 (2) 0.015782
SIRT1 C10S3050 0.170 (3) 0.008 (6) 0.002152
See Table 1 notes for an explanation of the notation.
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SNPs associated with Q4 is 3 to 6. Based on this range,
the SNPs whose average regression coefficients and PPAs
are within the top six rankings are considered associated
with Q4. Compared with the GAW17 answers, these
SNPs are false positives. We observed that the correlation
coefficient between Q1 and Q4 is −0.293 and that there
are 39 SNPs that are associated with Q1, which could be
the reason for these false positives.
The results for Q1 and Q2 demonstrate that our
model identified several true SNPs associated with Q1
and Q2 but missed many true positives for these two
traits. To assess the model’s performance for identifying
rare variants, based on the association results using all
S N P s ,w ee x t r a c tt h eS N P sw i t haM A Fl e s st h a n1 %
and calculate the AUCs using all SNPs and using the
rare variants only for Q1 and Q2. Table 3 shows that
the AUCs using all SNPs range from 0.774 to 0.808; the
AUCs using only the rare variants range from 0.699 to
0.724. We obtained a reasonable power to detect rare
variants using this model. However, it is obvious that
the power of our model to identify rare variants is less
than the power to identify common variants. These
r e s u l t sc o u l db ed u et ot h es m a l le f f e c t so fS N P sw i t h
lower MAFs, and our model shrinks their regression
coefficients to 0.
Several other factors could also have played a role in
causing the false negatives and false positives. First, we
observed that there is an outlier for the Q1 trait. Several
studies have shown that removing this outlier might
increase the detection power. Our analyses did not con-
sider these outliers, so we expected that we could
increase the power by removing the outliers in the sub-
sequent analyses. Second, the structure information of
the SNPs was not included in the model, although all
SNPs were modeled simultaneously. Many studies have
shown that collapsing SNPs into blocks based on linkage
disequilibrium, a gene, or a biological pathway can
increase the power to detect associations. In a future
study, we plan to model the correlations between the
SNPs or to collapse the SNPs into blocks first and then
apply this model to the blocks to see whether the detec-
tion power of this method can be increased.
Conclusions
In the present study, we modeled all SNPs simulta-
neously to study the association between the SNPs and
the quantitative risk traits Q1, Q2, and Q4 using a Baye-
sian regression method. Some true associated SNPs for
Q1 and Q2 were identified using this method. However,
our model missed many true positives and generated
several false positives, suggesting that there is room for
improvement.
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